Insurance cover

What NHIS pays for Carbamazepine Sustained-Release

Carbamazepine Sustained-Release (Carbamazepine Sustained-Release Tablet, 400 mg Tablet) is on the National Health Insurance Scheme medicines list, edition March 2025. The scheme reimburses providers ₵6.22 per 400 mg Tablet. It may be prescribed from District hospital level upward (District hospital and above). This is the scheme tariff, not a retail price.

Record

CARBAMTA4

Generic

Carbamazepine Sustained-Release

Presentation

Carbamazepine Sustained-Release Tablet, 400 mg Tablet

NHIS tariff

₵6.22

Level of prescribing

C · District hospital

Scheme code

CARBAMTA4

List edition

March 2025